223 related articles for article (PubMed ID: 28814166)
21. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
22. Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system.
Grüter T; Ayzenberg I; Gahlen A; Kneiphof J; Gold R; Kleiter I
Mult Scler Relat Disord; 2018 Oct; 25():83-86. PubMed ID: 30056360
[TBL] [Abstract][Full Text] [Related]
23. Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
Kim S; Park J; Kwon BS; Park JW; Lee HJ; Choi JH; Nam K
Mult Scler Relat Disord; 2017 Nov; 18():77-81. PubMed ID: 29141825
[TBL] [Abstract][Full Text] [Related]
24. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.
Cortese R; Magnollay L; Tur C; Abdel-Aziz K; Jacob A; De Angelis F; Yiannakas MC; Prados F; Ourselin S; Yousry TA; Barkhof F; Ciccarelli O
Neurology; 2018 Apr; 90(14):e1183-e1190. PubMed ID: 29514948
[TBL] [Abstract][Full Text] [Related]
25. Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
Massey J; Buckland ME; Barnett Y; Sutton I
BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27469383
[TBL] [Abstract][Full Text] [Related]
26. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
27. Aquaporin-4 neuromyelitis optica spectrum disorder in a 2-year-old girl: Diagnostic and treatment considerations.
Khan TR; Wang C
Mult Scler Relat Disord; 2020 Jun; 41():102030. PubMed ID: 32145694
[TBL] [Abstract][Full Text] [Related]
28. Effect of rituximab on disease activity in latin American patients with anti-aquaporin-4 (+) neuromyelitis optica spectrum disorder.
Gomez-Figueroa E; Noriega-Morales G; Casallas-Vanegas A; Zabala-Angeles I; Garcia-Estrada C; Neri D; Sarachaga AJ; Rivas-Alonso V; Corona-Vazquez T; Flores-Rivera J
Clin Neurol Neurosurg; 2020 Sep; 196():106007. PubMed ID: 32559706
[TBL] [Abstract][Full Text] [Related]
29. Neuromyelitis optica spectrum disorder presenting as rhomboencephalitis.
Stavrou M; Francis L; Tshuma N; Schmierer K
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29794010
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
31. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
[TBL] [Abstract][Full Text] [Related]
32. [Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Hervás-García JV; Grau-López L; Doménech-Puigcerver S; Ramo-Tello C
Rev Neurol; 2014 Jan; 58(1):20-4. PubMed ID: 24343537
[TBL] [Abstract][Full Text] [Related]
33. Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder.
Olivieri G; Nociti V; Iorio R; Stefanini MC; Losavio FA; Mirabella M; Mariotti P
Neurol Sci; 2015 Dec; 36(12):2301-2. PubMed ID: 26292790
[No Abstract] [Full Text] [Related]
34. Cortical oscillopsia without nystagmus, an isolated symptom of neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibody.
Kim SM; Kim JS; Heo YE; Yang HR; Park KS
Mult Scler; 2012 Feb; 18(2):244-7. PubMed ID: 21828199
[TBL] [Abstract][Full Text] [Related]
35. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica spectrum disorder mimicking stroke: A case report and literature review.
Hu B; Dang G; Chen S; Li S; Guo Y; Li Z
J Neuroimmunol; 2023 Dec; 385():578223. PubMed ID: 37992585
[TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial.
Nikoo Z; Badihian S; Shaygannejad V; Asgari N; Ashtari F
J Neurol; 2017 Sep; 264(9):2003-2009. PubMed ID: 28831548
[TBL] [Abstract][Full Text] [Related]
39. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
[TBL] [Abstract][Full Text] [Related]
40. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
